Knut Wendelin

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

Nicola Gökbuget, Daniel Stanze, Joachim Beck et al. · Blood · 2012 · 465 citations · Full text

Medicine, Hematology, Oncology +14

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

Hannes Wandt, Kerstin Schaefer‐Eckart, Knut Wendelin et al. · The Lancet · 2012 · 339 citations

Medicine, Hematology, Oncology +13

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, Joachim Beck, Monika Brüggemann et al. · Blood · 2012 · 78 citations

Medicine, Geriatric Medicine, Oncology +14

Significant Improvement Of Outcome In Adolescents and Young adults (AYAs) Aged 15-35 Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol; Results Of 1529 AYAs In 2 Consecutive Trials Of The German Multicenter Study Group For Adult ALL (GMALL)

Nicola Gökbuget, Joachim Beck, Kalina Brandt et al. · Blood · 2013 · 52 citations

Medicine, Hematology, Pediatrics +12

Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

Oliver G. Ottmann, Jean‐Michel Cayuela, Karsten Spiekermann et al. · Blood · 2018 · 51 citations · Full text

Medicine, Oncology, Pharmacology +11